Back

Transthyretin levels increase in patients with severe AS following TAVI

31 August 2026 (09:15 - 09:45)
Organised by: Logo
Congress Presentation Part of: Improving diagnosis and management of myocardial disease Pathophysiology and Mechanisms ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Evangelos Oikonomou

National & Kapodistrian University of Athens, Athens (Greece)

4 More presentations in this session

Presentation thumbnail
Mapping ATTR in Brazil: a meta-epidemiological analysis of regional genetic and clinical diversity
Doctor P. Duarte (Brasilia, BR)
Abstract
Presentation thumbnail
Combined assessment of left ventricular and atrial function for transthyretin amyloid cardiomyopathy
Ms A. Senda (Kobe, JP)
Abstract
Presentation thumbnail
Ventricular arrhythmias characteristics response to chemotherapy in light-chain cardiac amyloidosis
Doctor D. Yang (Beijing, CN)
Abstract
Presentation thumbnail
Ventricular–arterial coupling and long-term cardiovascular risk in Fabry disease
Doctor H. Chang (Taipei, TW)
Abstract

Access the full session

Session thumbnail
Improving diagnosis and management of myocardial disease

The Event

Event poster

ESC Congress 2026

31 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Transthyretin cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: a single center experience
29 August 2022
thumbnail
Congress Presentation
Human epididymal protein 4 reflects extracellular matrix accumulation and predicts the outcome of post-operative patients with severe aortic stenosis after transcatheter aortic valve implantation
1 September 2025
thumbnail
Congress Presentation
Impact of aortic valve replacement on outcomes of patients with low-flow, low-gradient moderate aortic stenosis
3 September 2019
thumbnail
Congress Presentation
Serum transthyretin before and after starting tafamidis as outcome predictors in ATTR cardiomyopathy
9 May 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources